NeuroMetrix(NURO) - 2024 Q1 - Quarterly Report
NURONeuroMetrix(NURO)2024-05-15 23:19

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ☒ 1934 For the quarterly period ended March 31, 2024 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF ☐ 1934 For the transition period from ____ to ____ Commission File Number 001-33351 _________________________________________________ NEUROMETRIX, INC. (Exact name of registrant as specified in it ...